- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk
Bibliographic Information
- Other Title
-
- Effect of sex mismatch and disease risk on HSCT outcome
Search this article
Description
Optimal donor selection is one of the key factors to enhance the success rate of allogeneic hematopoietic stem cell transplantation (HSCT). The effect of sex mismatch, especially the effect of Y chromosome mismatch in graft-versus-host disease (GVHD) direction (female donors to male recipients: denoted as FtoM mismatch) on overall survival (OS) has been controversial and not examined out of the patient population in Western countries. We retrospectively analyzed 225 cases of allogeneic HSCT and showed that FtoM mismatch confers a highly significant impact on OS (P0.005) in Japanese population. We demonstrated that this effect depends on the disease risk; for standard risk cases, this effect was significantly associated with poor outcome (for OS, P = 0.021), while for high risk cases, it had no effect on the results (for OS, P = 0.26). We further showed that FtoM mismatch was associated with nonrelapse mortality (P = 0.019) and most of them were GVHD-related in standard risk cases. In conclusion, FtoM mismatch has a significant impact on transplant outcome, especially in standard risk cases.
Journal
-
- Transplant International
-
Transplant International 24 (5), 469-476, 2011-02-05
Frontiers Media SA
- Tweet
Keywords
- Adult
- Male
- Risk
- Chromosomes, Human, Y
- Leukemia
- Adolescent
- Hematopoietic Stem Cell Transplantation
- Graft vs Leukemia Effect
- Middle Aged
- Sex Factors
- Treatment Outcome
- Blood Group Incompatibility
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Myelodysplastic Syndromes
- Humans
- Transplantation, Homologous
- Female
- Aged
- Retrospective Studies
Details 詳細情報について
-
- CRID
- 1360285710578506752
-
- ISSN
- 09340874
-
- PubMed
- 21294789
-
- Article Type
- journal article
-
- Data Source
-
- Crossref
- KAKEN
- OpenAIRE